Erratum to: Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia

Affiliations

• ¹ Mount Sinai Heart, Cardiometabolics Unit, Icahn School of Medicine at Mount Sinai, 1425 Madison Ave, MC1 Level, New York, NY, 10029, USA. [email protected].
• ² Emory University, 201 Dowman Drive, Atlanta, GA, 30322, USA.
• ³ Clinical Trial Service Unit and Epidemiological Studies Unit, Oxford University, Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford, OX3 7LF, UK.
• ⁴ Amgen Inc., One Amgen Center Dr, Thousand Oaks, CA, 91320, USA.
• ⁵ Amgen (Europe) GmbH, Dammstrasse 23, 6300, Zug, Switzerland.
• ⁶ Amgen Ltd, 240 Cambridge Science Park, Milton, Cambridge, CB4 0WD, UK.
• ⁷ University of Maryland School of Medicine, 655 W Baltimore St, Baltimore, MD, 21201, USA.